QIM
EGRX

Quantitative Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Quantitative Investment Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-9,400
Closed -$711K – 923
2018
Q2 		$711K Buy
+9,400
New +$591K 0.01% 550
2017
Q3 		– Sell
-55,400
Closed -$4.37M – 875
2017
Q2 		$4.37M Sell
55,400
-38,900
-41% -$3.18M 0.07% 356
2017
Q1 		$7.82M Buy
94,300
+66,700
+242% +$4.96M 0.12% 238
2016
Q4 		$2.19M Buy
+27,600
New +$2M 0.06% 464
2015
Q3 		– Sell
-9,200
Closed -$743K – 814
2015
Q2 		$743K Buy
+9,200
New +$599K 0.11% 170

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Quantitative Investment Management's EGRX Position: Q3 2018 in Review

Quantitative Investment Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2018, closing a stake of 9,400 shares — an estimated $711K sold.

Quantitative Investment Management first reported a position in EGRX in Q2 2015 and held it in 5 quarters. The position peaked at $7.82M in Q1 2017. 189 funds tracked by Wall St. Rank hold EGRX as of Q3 2018.

  • Quantitative Investment Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 9,400 Eagle Pharmaceuticals, Inc. shares in Q3 2018, an estimated $711K.
  • Quantitative Investment Management first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
  • Quantitative Investment Management's Eagle Pharmaceuticals, Inc. position peaked at $7.82M in Q1 2017.
  • 189 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2018.

Based on Quantitative Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.